Phase II capecitabine and gemcitabine fixed dose rate (FDR) in patients with advanced pancreatic cancer D. Santini,B. Vincenzi,G. Masi,V Catalano,V. Virzi,E. Vasile,A. Fontana,S. Intagliata,G. Catalano,A. Falcone, G. ToniniANNALS OF ONCOLOGY(2008)引用 2|浏览16暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要